Edition:
United Kingdom

argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

115.70EUR
17 May 2019
Change (% chg)

€0.20 (+0.17%)
Prev Close
€115.50
Open
€115.40
Day's High
€116.30
Day's Low
€113.80
Volume
84,173
Avg. Vol
117,093
52-wk High
€119.60
52-wk Low
€54.30

About

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)

Overall

Beta: 0.63
Market Cap(Mil.): €4,361.02
Shares Outstanding(Mil.): 37.69
Dividend: --
Yield (%): --

Financials

  ARGX.BR Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -1.25 -- --
ROI: -- 7.41 11.59
ROE: -- 7.88 16.33

Earnings vs. Estimates